Skip to main content
. 2020 Sep 15;10:15106. doi: 10.1038/s41598-020-72208-y

Table 2.

Details of Δ1 and Δ2, i.e. relative changes of T1, T1ρ, T2, and T2* at δ1 versus δ0 and at δ2 versus δ0 during the pre- and post-exposure measurement series, as a function of trypsin exposure, region-of-interest, and loading intensity.

Pre exposure Post exposure p value
Δ1pre Δ2pre Δ1post Δ2post Δ1pre vs. Δ1post Δ2pre vs. Δ2post
T1
Low trypsin
Entire − 3.7 ± 2.3 − 7.4 ± 3.2 − 3.4 ± 2.4 − 7.1 ± 2.6 1.000 1.000
SPA − 6.0 ± 2.2 − 10.2 ± 3.3 − 5.0 ± 2.7 − 10.4 ± 3.8 1.000 1.000
SPA upper − 8.6 ± 2.8 − 15.5 ± 4.6 − 8.0 ± 3.2 − 15.4 ± 4.1 0.922 0.922
SPA lower − 2.6 ± 3.7 − 3.5 ± 4.2 − 0.9 ± 4.1 − 3.8 ± 5.1 0.584 0.880
PPA − 0.6 ± 2.7 − 3.5 ± 3.3 − 1.0 ± 3.0 − 3.1 ± 3.0 1.000 1.000
PPA upper − 0.9 ± 2.8 − 4.7 ± 3.6 − 1.8 ± 4 − 4.3 ± 3.8 0.566 0.568
PPA lower 0.2 ± 4.7 − 1.5 ± 5.0 0.4 ± 2.9 − 0.5 ± 6.2 1.000 1.000
High trypsin
Entire − 5.0 ± 3.5 − 10.4 ± 4.2 − 6.4 ± 3.5 − 11.5 ± 2.4 0.720 0.720
SPA − 6.3 ± 4.1 − 12.6 ± 5.0 − 9.0 ± 2.6 − 15.2 ± 2.7 0.106 0.092
SPA upper − 9.6 ± 5.1 − 17.2 ± 6.5 − 15.1 ± 5.4 − 23.0 ± 5.8 0.002 0.003
SPA lower − 2.0 ± 4.2 − 6.7 ± 4.6 − 0.8 ± 6.8 − 4.6 ± 4.1 0.706 0.494
PPA − 2.7 ± 3.3 − 6.7 ± 4.0 − 2.4 ± 5.2 − 6.2 ± 3.6 1.000 1.000
PPA upper − 4.0 ± 4.8 − 8.4 ± 5.6 − 4.8 ± 5.2 − 9.0 ± 5.1 1.000 1.000
PPA lower − 1.7 ± 4.0 − 4.3 ± 2.6 2.4 ± 8.8 − 0.2 ± 6.1 0.172 0.152
Controls
Entire − 4.3 ± 2.5 − 8.4 ± 2.1 − 4.2 ± 2.2 − 8.1 ± 3.1 1.000 1.000
SPA − 4.9 ± 2.4 − 9.2 ± 2.3 − 5.5 ± 3.1 − 9.6 ± 3.2 0.650 0.745
SPA upper − 7.7 ± 4.5 − 13.9 ± 4.1 − 8.8 ± 4.0 − 14.8 ± 3.3 0.594 0.594
SPA lower − 2.1 ± 2.8 − 4.1 ± 3.6 − 1.7 ± 3.7 − 2.6 ± 5.0 0.908 0.908
PPA − 2.8 ± 2.9 − 6.7 ± 4.4 − 2.1 ± 1.8 − 5.9 ± 4.0 0.768 0.768
PPA upper − 3.9 ± 3.1 − 8.7 ± 5.0 − 3.5 ± 2.7 − 9.0 ± 5.1 1.000 1.000
PPA lower − 0.9 ± 3.6 − 2.1 ± 4.7 0.2 ± 4.0 − 1.2 ± 5.3 1.000 1.000
T1ρ
Low trypsin
Entire 13.3 ± 3.6 15.5 ± 6.2 12.2 ± 4.5 12.0 ± 7.4 0.367 0.140
SPA 15.5 ± 4.5 16.9 ± 7.9 13.8 ± 6.0 13.2 ± 7.2 1.000 1.000
SPA upper 21.3 ± 6.4 20.9 ± 7.9 18.8 ± 5.9 16.7 ± 8.3 0.324 0.324
SPA lower 9.4 ± 8.1 12.8 ± 11.3 8.7 ± 11.8 10.3 ± 12.5 0.765 0.082
PPA 9.1 ± 4.1 12.6 ± 4.6 9.9 ± 6.0 11.3 ± 10.0 1.000 1.000
PPA upper 12.6 ± 6 15.8 ± 5.2 13.6 ± 9.4 14.3 ± 11.4 1.000 1.000
PPA lower 5.4 ± 5.7 9.1 ± 6.1 5.5 ± 10.1 7.9 ± 13.1 1.000 1.000
High trypsin
Entire 13.5 ± 8.2 15.4 ± 9.4 12.6 ± 10.2 17.1 ± 26.2 1.000 1.000
SPA 16.1 ± 9.2 17.6 ± 10.7 14.4 ± 12.1 20.2 ± 32.9 1.000 1.000
SPA upper 18.2 ± 9.5 17.3 ± 13.1 15.0 ± 13.5 17.1 ± 30.8 1.000 1.000
SPA lower 13.8 ± 9.8 18.4 ± 10.5 14.0 ± 13.4 24.6 ± 36.5 1.000 1.000
PPA 8.2 ± 8.4 11.4 ± 9.3 8.3 ± 9.3 10.7 ± 9.3 1.000 1.000
PPA upper 9.1 ± 8.7 11.6 ± 8.0 7.2 ± 9.8 7.4 ± 12.0 0.508 0.486
PPA lower 6.9 ± 9.7 11.1 ± 11.8 10.1 ± 11.8 15.8 ± 11.8 0.646 0.646
Controls
Entire 8.9 ± 4.6 9.3 ± 5.7 13.3 ± 6.1 15.9 ± 7.0 0.084 0.034
SPA 10.8 ± 4.4 11.5 ± 5.6 15.3 ± 5.4 17.8 ± 6.6 0.061 0.040
SPA upper 14.8 ± 6.3 13.4 ± 6.2 19.3 ± 8.5 20.8 ± 9.4 0.104 0.070
SPA lower 6.7 ± 9.3 9.6 ± 10.7 11.4 ± 11.2 14.9 ± 12.2 0.187 0.166
PPA 4.3 ± 6.6 4.2 ± 8.1 8.2 ± 7.7 11.4 ± 8.7 0.209 0.030
PPA upper 5.2 ± 7.5 5.3 ± 7.7 11.5 ± 7.8 12.9 ± 9.6 0.059 0.012
PPA lower 3.2 ± 10.3 2.8 ± 11.5 4.9 ± 9.1 9.7 ± 9.4 0.665 0.200
T2
Low trypsin
entire 5.5 ± 3.2 4.2 ± 5.6 2.4 ± 3.8 1.9 ± 7.2 0.064 0.237
SPA 5.0 ± 4.4 2.9 ± 7.7 1.4 ± 3.9 − 0.2 ± 7.6 0.244 0.667
SPA upper 5.1 ± 5.7 1.4 ± 7.5 0.0 ± 5.5 − 4.3 ± 8.8 0.020 0.076
SPA lower 4.9 ± 5.9 5.9 ± 12.2 3.6 ± 6.0 6.3 ± 8.7 1.000 1.000
PPA 6.2 ± 3.3 6.4 ± 4.9 4.1 ± 4.6 5.6 ± 9.1 0.244 0.667
PPA upper 8.0 ± 2.7 7.1 ± 5.1 4.9 ± 5.0 5.7 ± 9.3 0.042 0.466
PPA lower 4.2 ± 5.6 6.2 ± 6.1 2.1 ± 6.3 5.1 ± 10.8 0.842 0.842
High trypsin
Entire 1.1 ± 3.3 − 0.3 ± 5.1 − 1.5 ± 4.2 − 6.2 ± 6.4 0.210 0.026
SPA − 0.2 ± 4.7 − 2.9 ± 7.4 − 3.0 ± 6.2 − 9.9 ± 9.0 0.235 0.008
SPA upper − 0.5 ± 6.5 − 7.4 ± 9.9 − 4.9 ± 8.4 − 15.2 ± 11.8 0.188 0.014
SPA lower 0.2 ± 4.7 3.7 ± 7.1 0.2 ± 7.7 − 0.9 ± 10.8 0.998 0.126
PPA 3.5 ± 5.4 3.8 ± 5.1 0.9 ± 5.5 1.0 ± 6.8 0.468 0.468
PPA upper 4.7 ± 6.1 3.8 ± 7.0 1.3 ± 6.5 0.0 ± 7.8 0.328 0.328
PPA lower 1.7 ± 7.2 3.0 ± 6.1 0.2 ± 6.3 3.1 ± 7.4 1.000 1.000
Controls
Entire 0.2 ± 3.8 − 2.9 ± 4.7 − 1.1 ± 4.7 − 2.8 ± 4.7 0.986 0.997
SPA − 0.5 ± 4.4 − 3.7 ± 5.2 − 2.1 ± 5.0 − 4.4 ± 4.5 0.892 0.892
SPA upper 0.8 ± 3.3 − 5.8 ± 4 − 1.4 ± 5.5 − 5.9 ± 4.9 0.366 0.961
SPA lower − 1.6 ± 6.1 − 0.9 ± 8.1 − 3.2 ± 5.6 − 2.0 ± 8.9 1.000 1.000
PPA 2.4 ± 4.6 − 0.2 ± 5.7 1.2 ± 5.0 0.5 ± 7.2 1.000 1.000
PPA upper 2.9 ± 5.1 − 0.5 ± 5.2 3.6 ± 3.6 0.2 ± 7.9 1.000 1.000
PPA lower 0.5 ± 5.9 − 1.1 ± 6.4 0.3 ± 8.1 1.4 ± 8.5 0.926 0.470
T2*
Low trypsin
Entire 8.3 ± 6.8 7.0 ± 6.1 5.0 ± 3.9 3.2 ± 4.9 0.136 0.136
SPA 8.2 ± 7.7 6.1 ± 8.4 3.9 ± 4.3 1.5 ± 5.1 0.310 0.310
SPA upper 5.1 ± 8.7 2.5 ± 8.6 − 0.1 ± 7.1 − 2.6 ± 7.0 0.028 0.061
SPA lower 12.7 ± 11 11.9 ± 11.4 10.7 ± 9.5 8.8 ± 6.0 0.868 0.868
PPA 8.4 ± 6.2 8.7 ± 4.5 6.6 ± 4.3 6.3 ± 7.6 0.310 0.310
PPA upper 8.6 ± 6.4 7.7 ± 4.8 5.4 ± 7.4 4.9 ± 8.8 0.002 0.253
PPA lower 8.8 ± 6.6 11.2 ± 5.7 7.9 ± 7.4 8.0 ± 10.0 0.806 0.806
High trypsin
Entire 3.6 ± 4.3 1.2 ± 6.1 2.7 ± 6.3 − 8.2 ± 14.6 0.657 0.046
SPA 2.2 ± 5.4 − 1.5 ± 8.1 1.6 ± 8.8 − 11.6 ± 17.2 0.800 0.074
SPA upper 0.3 ± 7.4 − 6.8 ± 10.3 − 2.9 ± 11.5 − 16.3 ± 18.4 0.327 0.056
SPA lower 5.3 ± 6.4 7.4 ± 9.7 7.2 ± 8.2 − 4.1 ± 20.2 0.248 0.130
PPA 6.2 ± 5.3 6.2 ± 5.5 4.7 ± 6.3 − 0.8 ± 13.1 0.463 0.088
PPA upper 4.7 ± 6.8 4.5 ± 9.1 2.2 ± 9.6 − 1.3 ± 11.8 0.365 0.046
PPA lower 8.9 ± 8.7 8.3 ± 7.2 8.4 ± 7.7 1.0 ± 18.3 0.875 0.500
Controls
Entire 2.0 ± 5.3 − 0.5 ± 6.1 0.1 ± 5.2 − 2.3 ± 4.5 0.788 0.788
SPA 1.0 ± 5.8 − 1.3 ± 6.5 − 1.2 ± 5.6 − 3.9 ± 4.5 0.552 0.552
SPA upper 0.8 ± 5.5 − 3.3 ± 6.4 − 2.7 ± 5.6 − 7.2 ± 4.5 0.230 0.230
SPA lower 1.9 ± 7.2 1.1 ± 9.6 1.1 ± 6.8 0.8 ± 7.3 1.000 1.000
PPA 6.4 ± 10.6 3.0 ± 8.8 2.5 ± 4.6 0.9 ± 7.0 0.730 0.730
PPA upper 5.6 ± 10.2 0.8 ± 9.1 3.8 ± 5.3 0.2 ± 8.1 1.000 1.000
PPA lower 7.5 ± 20.3 6.2 ± 14.6 3.7 ± 8.4 3.2 ± 9.4 1.000 1.000

Pre- and post-exposure values of Δ1 and Δ2 were comparatively evaluated using paired Student's t-tests. Data are mean ± standard deviation [%]. Significant differences are indicated in bold type.